Status:
COMPLETED
Comparative Efficacy of 3L and 2L Integrated Techniques for Gynecologic Cancer-related Lower Extremity Lymphedema: a Retrospective Study
Lead Sponsor:
Zunyi Medical College
Conditions:
Gynecologic Cancer-related Lower Extremity Lymphedema
Lymphedema
Eligibility:
FEMALE
18-90 years
Brief Summary
The goal of this retrospective study is to evaluate the long-term efficacy of 3L versus 2L integrated techniques in patients with gynecologic cancer-related lower extremity lymphedema (GCR-LEL). The m...
Eligibility Criteria
Inclusion
- The patients diagnosed with gynecological cancer-related lymphedema by clinical examination are classified by the International Lymphedema Society (ISL) guidelines as Stage II to III.
- .Aged 18-90 years.
Exclusion
- Lactation, for patients with pregnancy;
- Serious heart, lung, liver, kidney disease, as well as the history of tumor patients;
- Disease history is less than 3 months;
- In patients with mental illness;
- Immunodeficiency patients.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06920732
Start Date
April 1 2018
End Date
December 31 2023
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China, 563003